Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

He Jing

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Cancer|June 3, 2015
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancerKaren L Reckamp, Marianna Koczywas, Mihaela C Cristea, et al.
Cell Reports|November 3, 2024
Extracellular vesicle-packaged PD-L1 impedes macrophage-mediated antibacterial immunity in preexisting malignancyHe-Jing Zhang, Lingxin Zhu, Qi-Hui Xie, et al.
Archives of Neurology|May 16, 2007
Testosterone treatment in multiple sclerosis: a pilot studyNancy L Sicotte, Barbara S Giesser, Vinita Tandon, et al.
Journal of the National Cancer Institute|January 17, 2003
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancerGottfried Konecny, Giovanni Pauletti, Mark Pegram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapyTakuji Mori, Steven J O'Day, Naoyuki Umetani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patientsGottfried E Konecny, Y Gloria Meng, Michael Untch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanomaLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Gynecologic Oncology|March 27, 2016
Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signaturesBoris Winterhoff, Habib Hamidi, Chen Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2022
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Alistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Cancer|June 3, 2015
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancerKaren L Reckamp, Marianna Koczywas, Mihaela C Cristea, et al.
Cell Reports|November 3, 2024
Extracellular vesicle-packaged PD-L1 impedes macrophage-mediated antibacterial immunity in preexisting malignancyHe-Jing Zhang, Lingxin Zhu, Qi-Hui Xie, et al.
Archives of Neurology|May 16, 2007
Testosterone treatment in multiple sclerosis: a pilot studyNancy L Sicotte, Barbara S Giesser, Vinita Tandon, et al.
Journal of the National Cancer Institute|January 17, 2003
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancerGottfried Konecny, Giovanni Pauletti, Mark Pegram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapyTakuji Mori, Steven J O'Day, Naoyuki Umetani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patientsGottfried E Konecny, Y Gloria Meng, Michael Untch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanomaLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Gynecologic Oncology|March 27, 2016
Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signaturesBoris Winterhoff, Habib Hamidi, Chen Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2022
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Alistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.
Pageof 17